questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrio
Vibrio cholerae
Vibrio cholerae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Choléra
Diagnostic microbiologique
Tests de diagnostic
Vibrio cholerae
Période d'incubation
Choléra
Symptômes
5
Choléra
Portage asymptomatique
Traitements
5
Traitement du choléra
Réhydratation
Efficacité du traitement
Choléra
Facteurs de risque
5
Facteurs de risque
Choléra
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae : Questions médicales les plus fréquentes",
"headline": "Vibrio cholerae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrio cholerae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-28",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Firdausi Qadri",
"url": "https://questionsmedicales.fr/author/Firdausi%20Qadri",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Munirul Alam",
"url": "https://questionsmedicales.fr/author/Munirul%20Alam",
"affiliation": {
"@type": "Organization",
"name": "International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Shanta Dutta",
"url": "https://questionsmedicales.fr/author/Shanta%20Dutta",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India."
}
},
{
"@type": "Person",
"name": "Shelley M Payne",
"url": "https://questionsmedicales.fr/author/Shelley%20M%20Payne",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu."
}
},
{
"@type": "Person",
"name": "Bibhuti Bhusan Pal",
"url": "https://questionsmedicales.fr/author/Bibhuti%20Bhusan%20Pal",
"affiliation": {
"@type": "Organization",
"name": "Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "In platelet single donor apheresis, platelet factor 4 levels correlated with donor's age and decreased during storage.",
"datePublished": "2024-03-14",
"url": "https://questionsmedicales.fr/article/38485973",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-56826-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity.",
"datePublished": "2023-05-07",
"url": "https://questionsmedicales.fr/article/37150909",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ijlh.14075"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37394121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.06.026"
}
},
{
"@type": "ScholarlyArticle",
"name": "Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study.",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37247669",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.05.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36107495",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jth.15881"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vibrio",
"item": "https://questionsmedicales.fr/mesh/D014733"
},
{
"@type": "ListItem",
"position": 7,
"name": "Vibrio cholerae",
"item": "https://questionsmedicales.fr/mesh/D014734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrio cholerae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrio cholerae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrio cholerae",
"description": "Comment diagnostiquer une infection par Vibrio cholerae ?\nQuels tests sont utilisés pour confirmer le choléra ?\nQuels symptômes indiquent une infection par Vibrio cholerae ?\nQuelle est la période d'incubation du choléra ?\nComment différencier le choléra d'autres diarrhées ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrio cholerae",
"description": "Quels sont les principaux symptômes du choléra ?\nComment se manifeste la déshydratation dans le choléra ?\nLe choléra peut-il être asymptomatique ?\nQuels signes indiquent une déshydratation sévère ?\nLes symptômes du choléra apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrio cholerae",
"description": "Comment prévenir l'infection par Vibrio cholerae ?\nLa vaccination contre le choléra est-elle efficace ?\nQuelles mesures d'hygiène sont recommandées ?\nComment l'eau potable peut-elle prévenir le choléra ?\nLes voyages dans des zones à risque nécessitent-ils des précautions ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrio cholerae",
"description": "Quel est le traitement principal du choléra ?\nLes antibiotiques sont-ils nécessaires pour le choléra ?\nComment prévenir la déshydratation dans le choléra ?\nQuels médicaments sont utilisés pour traiter le choléra ?\nLe traitement du choléra est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrio cholerae",
"description": "Quelles sont les complications possibles du choléra ?\nLe choléra peut-il entraîner la mort ?\nComment la déshydratation affecte-t-elle le corps ?\nQuelles sont les conséquences à long terme du choléra ?\nLe choléra peut-il causer des épidémies ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrio cholerae",
"description": "Quels sont les facteurs de risque du choléra ?\nLes enfants sont-ils plus à risque de choléra ?\nComment la malnutrition influence-t-elle le choléra ?\nLes personnes vivant dans des zones urbaines sont-elles à risque ?\nLes voyageurs peuvent-ils être exposés au choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Platelet+Factor+4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrio cholerae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture de selles ou tests PCR pour détecter la bactérie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le choléra ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de culture des selles et les tests rapides de détection d'antigènes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Vibrio cholerae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quelle est la période d'incubation du choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La période d'incubation est généralement de 1 à 5 jours après l'exposition."
}
},
{
"@type": "Question",
"name": "Comment différencier le choléra d'autres diarrhées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se caractérise par une diarrhée aqueuse profuse et une déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes du choléra ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux symptômes sont diarrhée aqueuse, vomissements, crampes abdominales."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la déshydratation dans le choléra ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation se manifeste par soif intense, sécheresse de la peau et fatigue."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il être asymptomatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être porteuses sans présenter de symptômes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une déshydratation sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, tachycardie, hypotension et urines très rares."
}
},
{
"@type": "Question",
"name": "Les symptômes du choléra apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par Vibrio cholerae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'accès à l'eau potable, l'hygiène et la vaccination."
}
},
{
"@type": "Question",
"name": "La vaccination contre le choléra est-elle efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent réduire le risque d'infection, surtout en zones à risque."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains fréquemment et consommer des aliments bien cuits sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment l'eau potable peut-elle prévenir le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eau potable et propre empêche l'ingestion de Vibrio cholerae, réduisant le risque."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque nécessitent-ils des précautions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé de se faire vacciner et de suivre des mesures d'hygiène strictes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du choléra ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la réhydratation orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour le choléra ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être utilisés pour réduire la durée de la diarrhée et la gravité."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans le choléra ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation rapide avec des solutions de réhydratation orale est essentielle."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme la doxycycline ou l'azithromycine sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Le traitement du choléra est-il efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement rapide et approprié est très efficace pour réduire la mortalité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du choléra ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent déshydratation sévère, choc hypovolémique et insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement rapide, le choléra peut être mortel en raison de la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation affecte-t-elle le corps ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des déséquilibres électrolytiques et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences à long terme du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des problèmes de santé persistants, comme des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il causer des épidémies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut provoquer des épidémies, surtout dans des conditions d'hygiène précaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du choléra ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accès limité à l'eau potable, la malnutrition et l'absence d'hygiène."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de choléra ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées sont plus vulnérables aux complications du choléra."
}
},
{
"@type": "Question",
"name": "Comment la malnutrition influence-t-elle le choléra ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition affaiblit le système immunitaire, augmentant le risque d'infection par choléra."
}
},
{
"@type": "Question",
"name": "Les personnes vivant dans des zones urbaines sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les zones urbaines surpeuplées avec un accès limité à l'eau potable sont à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs peuvent-ils être exposés au choléra ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des régions endommagées par le choléra doivent prendre des précautions."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: smruti2007rkl@gmail.com.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Centre for Human Microbial Ecology, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad 121001, India; School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Electronic address: bhabatosh@thsti.res.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Maryland Pathogen Research Institute, University of Maryland, College Park, MD, 20742, USA.
Institute for Advanced Computer Studies, University of Maryland, University of Maryland, College Park, MD, 20742, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Division of Global Health, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Microbiology, Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, MA, USA; Howard Hughes Medical Institute, Bethesda, MD, USA. Electronic address: mwaldor@research.bwh.harvard.edu.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences of Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, Okayama, 700-8530, Japan. Electronic address: k-oka@xd6.so-net.ne.jp.
Publications dans "Vibrio cholerae" :
2 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
Publications dans "Vibrio cholerae" :
The human population is ageing worldwide. The World Health Organization estimated that the world's population of people aged 60 years and older will increase to at least 30%, coinciding with a growing...
Platelet factor 4 (PF4, synonym: CXCL4) is an evolutionary old chemokine with proposed roles in hemostasis and antimicrobial defense. In addition, PF4 has attracted considerable attention as a crucial...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication of adenoviral vector-based vaccines against SARS-CoV-2. This syndrome is caused by antibodies against platelet factor 4...
We aim to characterize the relationship of VITT platelet-activating profiles with CVST....
We conducted a retrospective cohort study involving patients with confirmed VITT who were tested between March and June 2021. Data were collected with an anonymized form and cases were identified as V...
Of the patients with confirmed VITT (n = 39), 17 (43.6%) had PF4-dependent antibodies and 22 (56.4%) had PF4-independent antibodies. CVST occurred almost exclusively in PF4-independent patients (11 of...
These findings suggest that VITT antibodies that cause PF4-independent platelet activation represent a unique subset of patients more likely to be associated with CVST, possibly due to the 2 different...
Anecdotal reports suggest that the correlation between heparin/platelet factor 4 (PF4) antibody assays for the diagnosis of heparin-induced thrombocytopenia (HIT) is limited....
To investigate the correlation between widely used assays and examine possible factors contributing to variability....
This is a large, prospective cohort study with 10 participating tertiary care hospitals including 1393 patients with suspected HIT in clinical practice. HIT was defined by a positive heparin-induced p...
Among 1393 patients, 119 were classified as HIT-positive (prevalence, 8.5%). The median 4Ts score was 5 (IQR, 4-6) in patients with HIT compared with 3 (IQR, 2-4) in patients without HIT. Correlations...
The correlation between widely used heparin/PF4 antibody assays was weak, and key factors could not explain this variability. Standardization of immunoassays is requested to improve comparability....
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus-based vaccines aimed to prevent and minimize COVID-19 and related pathophysiology....
To describe patterns of testing for anti-platelet factor 4 (PF4) antibodies using various ELISA assays in a large Australian cohort and comparative functional platelet activation assays in a subset....
Asserachrom HPIA IgG ELISA was performed in 1284 patients over a period of 12 months, supplemented in select cohorts by comparative ELISA using three other methods (n = 78-179), three different functi...
For first episode presentations, 190/1284 (14.8%) ELISA tests were positive. Conversely, most (445/460; 96.7%) chemiluminescence anti-PF4 test results were negative. All functional assays showed assoc...
To our knowledge, this is the largest multicenter evaluation of anti-PF4 testing for investigation of VITT. Discrepancies in test results (ELISA vs. ELISA or ELISA vs. functional assay) in some patien...
The molecules human interleukin (IL-18), the soluble cluster of differentiation (sCD40), platelet factor 4 variant 1 (PF4V1), and neutrophil gelatinase-associated lipocalin (NGAL) are all markers of i...
30 OABD and 30 OIBD and 30 healthy individuals were included in the study. IL-18, sCD40, PF4V1, and NGAL molecules were studied in blood samples by the ELISA method....
When OABD and OIBD were compared to healthy individuals, the levels of IL-18, sCD40, PF4V1, and NGAL molecules were found to be statistically significant. These values were even more significantly hig...
When ROC values of IL-18, sCD40, PF4V1, and NGAL are evaluated, it is clear that these four molecules can be used as biomarkers to aid activity and diagnosis in OBD....
Fibrosis represents the common end stage of chronic organ injury independent of the initial insult, destroying tissue architecture and driving organ failure. Here we discover a population of profibrot...
The aging process profoundly impacts the systemic milieu, with specific blood-borne factors playing critical roles in its regulation. Platelet Factor 4 (PF4), released by platelets, has emerged as a n...
Heparin-induced thrombocytopenia (HIT) is a severe immune-mediated prothrombotic disorder caused by antibodies (Ab) reactive to complexes of platelet factor 4 and heparin. Platelets (PLT) and their in...
Heparin-induced thrombocytopenia, which results from production of antibodies that bind to heparin-platelet factor 4 (PF4) complexes, is a hypercoagulable state associated with considerable morbidity ...
We conducted a cohort study of hospitalized adults who underwent testing for PF4 antibodies at two large medical centers in Boston between 2015 and 2021. The primary exposure was PF4 test positivity. ...
A total of 4224 patients were included in our analysis, 469 (11.1%) of whom had a positive PF4 test. Severe AKI occurred in 50 of 469 patients (10.7%) with a positive PF4 test and in 235 of 3755 (6.3%...
Among hospitalized adults, the presence of PF4 antibodies is independently associated with a 56% higher odds of developing severe AKI. Additional studies are needed to investigate potential mechanisms...